No Immunological Interference or Safety Concerns When Adjuvanted Recombinant Zoster Vaccine Is Coadministered With a Coronavirus Disease 2019 mRNA-1273 Booster Vaccine in Adults Aged 50 Years and Older: A Randomized Trial

BACKGROUND: There is growing consensus that coronavirus disease 2019 booster vaccines may be coadministered with other age-appropriate vaccines. Adding to the limited available data supporting coadministration, especially with adjuvanted vaccines, could enhance vaccine coverage in adults. METHODS: I...

Descripción completa

Detalles Bibliográficos
Autores principales: Naficy, Abdi, Kuxhausen, Adrienne, Pirrotta, Paola, Leav, Brett, Miller, Jacqueline, Anteyi, Kate, Danier, Jasur, Breuer, Thomas, Mwakingwe-Omari, Agnes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640691/
https://www.ncbi.nlm.nih.gov/pubmed/37335963
http://dx.doi.org/10.1093/cid/ciad361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640691/
https://www.ncbi.nlm.nih.gov/pubmed/37335963
http://dx.doi.org/10.1093/cid/ciad361

Ejemplares similares